OpenVSafe by OpenVAERS
Search V-safe

2PM-14498-12406

3 vaccinations 3 coded responses 36 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
481 / MI
Registered
2021-03-24
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-24
    Registered in v-safe
  2. 2021-03-24
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-24
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-03-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-03-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-03-31
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-04-07
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-14
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-14
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  14. 2021-04-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Fatigue or tiredness
    Adult check-in
  15. 2021-04-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Swollen lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-04-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-04-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-04-21
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-04-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-07
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-12
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-19
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-26
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-07-14
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-10-13
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-10-20
    Dose 3 — Pfizer-BioNTech
  28. 2021-10-21
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  29. 2021-10-22
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  30. 2021-10-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  31. 2021-10-26
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  32. 2021-10-27
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  33. 2021-11-03
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  34. 2021-11-11
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  35. 2021-11-17
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-11-25
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-12-01
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  38. 2022-01-19
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-04-20
    Survey response — 6 months, dose 3
    MedDRA: Pregnancy — Feeling: Good
    Free text: Pregnancy
    MedDRA releases: 2024-11 · check-in free text available
  40. 2022-10-20
    Survey response — 12 months, dose 3
    MedDRA: Delivery — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: C section delivery of baby
    MedDRA releases: 2024-11 · check-in free text available
  41. 2022-10-20
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Hospitalization · 1 call case(s)
  42. 2022-10-21
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-03-24Pfizer-BioNTech
22021-04-14Pfizer-BioNTech
32021-10-20Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-10-20 Successful
2022-10-21
 Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-16

Systemic reaction (other): Swollen lymph nodes

Release 11 — 6 months, dose 3

2022-04-20

Symptoms: Pregnancy

Release 12 — 12 months, dose 3

2022-10-20

Symptoms: C section delivery of baby

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDelivery · · ✓
SDPregnancy · · ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…